ABCA7 and Alzheimer disease: ABCA7 deletion in AD mouse models has shown increased amyloid deposition and decreased phagocytic uptake of oligomeric Aβ1–40 and Aβ1–42 in both macrophages and microglia, without changing microglial activation status [122,130].